ProCE Banner Activity

Expert Guidance for the Treatment of CLL: An International Perspective


Use this Interactive Decision Support Tool to compare your choice of therapy for patients with CLL with those of 5 renowned experts from the United Kingdom, France, Italy, Germany, and the Netherlands.

Released: May 01, 2023



Florence Cymbalista

Florence Cymbalista,

University Sorbonne Paris Nord
Bobigny, France

Toby Eyre

Toby Eyre, MBChB, MD

Honorary Senior Lecturer
Hematology and Cancer
University of Oxford
Consultant Hematologist
Department of Hematology
Hematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom

Arnon Kater

Arnon Kater, MD, PhD

Deputy Head
Department of Hematology
Amsterdam University Medical Centers
University of Amsterdam
Amsterdam, Netherlands

Stephan Stilgenbauer

Stephan Stilgenbauer, MD

Prof. Dr. Med. Stephan Stilgenbauer

Medical Director Comprehensive Cancer Center Ulm (CCCU)

Head Early Clinical Trials Unit (ECTU)

Head Division of CLL Department of Internal Medicine III

Ulm University

Ulm, Germany

Alessandra Tedeschi

Alessandra Tedeschi, MD

Director of Indolent Lymphoproliferative Disorders
Department of Hematology
Niguarda Cancer Center
Niguarda Hospital
Milan, Italy

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from AstraZeneca